Assembly Biosciences, Inc. Restructuring Charges
Assembly Biosciences, Inc. (ASMB) reported Restructuring Charges of $0 for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-28.
Discontinued › Expense Statement › Operating Expenses
us-gaap:RestructuringCharges · last filed 2024-03-28
- Assembly Biosciences, Inc. restructuring charges for the quarter ending 2023-12-31 was $0.00.
- Assembly Biosciences, Inc. restructuring charges for the quarter ending 2023-09-30 was $0.00, a 100.00% decline year-over-year.
- Assembly Biosciences, Inc. restructuring charges for the quarter ending 2023-06-30 was $0.00, a 100.00% decline year-over-year.
- Assembly Biosciences, Inc. restructuring charges for the quarter ending 2023-03-31 was $0.00.
- Assembly Biosciences, Inc. restructuring charges for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- Assembly Biosciences, Inc. restructuring charges for fiscal 2022 was $1.10M, a 31.72% decline from fiscal 2021.
- Assembly Biosciences, Inc. restructuring charges for fiscal 2021 was $1.61M, a 58.08% decline from fiscal 2020.
- Assembly Biosciences, Inc. restructuring charges for fiscal 2020 was $3.84M, a 83.52% increase from fiscal 2019.
| Period end | Restructuring Charges 1 month | Restructuring Charges 1 month as first filed | Restructuring Charges 3 month | Restructuring Charges 3 month as first filed | Restructuring Charges 6 month | Restructuring Charges 9 month | Restructuring Charges 12 month | Restructuring Charges 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $0.00 derived: sum of 2 quarters · filed 2024-03-28 | $0.00 derived: sum of 3 quarters · filed 2024-03-28 | $0.00 10-K · filed 2024-03-28 | ||||
| 2023-09-30 | $0.00 10-Q · filed 2023-11-08 | $0.00 derived: sum of 2 quarters · filed 2023-11-08 | $0.00 10-Q · filed 2023-11-08 | -$700.00K derived: sum of 4 quarters · filed 2024-03-28 | ||||
| 2023-06-30 | $0.00 10-Q · filed 2023-08-09 | $0.00 10-Q · filed 2023-08-09 | -$700.00K derived: sum of 3 quarters · filed 2024-03-28 | $100.00K derived: sum of 4 quarters · filed 2024-03-28 | ||||
| 2023-03-31 | $0.00 10-Q · filed 2023-05-04 | -$700.00K derived: sum of 2 quarters · filed 2024-03-28 | $100.00K derived: sum of 3 quarters · filed 2024-03-28 | $1.10M derived: sum of 4 quarters · filed 2024-03-28 | ||||
| 2022-12-31 | -$700.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $100.00K derived: sum of 2 quarters · filed 2024-03-28 | $1.10M derived: sum of 3 quarters · filed 2024-03-28 | $1.10M 10-K · filed 2024-03-28 | $1.88M 10-K · filed 2023-03-22 | |||
| 2022-09-30 | $800.00K 10-Q · filed 2023-11-08 | $835.00K 10-Q · filed 2022-11-08 | $1.80M derived: sum of 2 quarters · filed 2023-11-08 | $1.80M 10-Q · filed 2023-11-08 | ||||
| 2022-07-31 | $1.10M 10-K · filed 2023-03-22 | $1.80M 10-Q · filed 2022-11-08 | ||||||
| 2022-06-30 | $1.00M 10-Q · filed 2023-08-09 | $1.00M 10-Q · filed 2023-08-09 | ||||||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-22 | $0.00 derived: sum of 2 quarters · filed 2023-03-22 | $0.00 derived: sum of 3 quarters · filed 2023-03-22 | $1.61M 10-K · filed 2023-03-22 | ||||
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $0.00 derived: sum of 2 quarters · filed 2021-11-04 | $1.61M 10-Q · filed 2021-11-04 | |||||
| 2021-07-31 | $1.10M 10-Q · filed 2023-05-04 | |||||||
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $1.61M 10-Q · filed 2021-08-05 | ||||||
| 2021-03-31 | $1.61M 10-Q · filed 2021-05-06 | |||||||
| 2020-12-31 | $3.84M 10-K · filed 2022-03-11 | $5.68M 10-K · filed 2021-02-25 | ||||||
| 2019-12-31 | $2.09M 10-K · filed 2021-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |